Results 31 to 40 of about 30,734 (250)

Electrically atomised formulations of timolol maleate for direct and on-demand ocular lens coatings [PDF]

open access: yes, 2017
The file attached to this record is the author's final peer reviewed version.
Ahmad, Zeeshan   +6 more
core   +2 more sources

Timolol Maleate Gel Forming Solution [PDF]

open access: yesDefinitions, 2020
A gel forming solution containing the maleate salt of timolol, a propanolamine derivative and a non-selective beta-adrenergic antagonist, with intraocular pressure-reducing activity.
openaire   +2 more sources

The parallel lives of polysaccharides in food and pharmaceutical formulations [PDF]

open access: yes, 2015
The present opinion article discusses how polysaccharide structures can be used in both food and pharmaceutical formulations. We distinguish two regions depending on moisture content where polysaccharides form structures with distinct functional ...
Kontogiorgos, Vassilis   +2 more
core   +1 more source

24-h Efficacy of Glaucoma Treatment Options [PDF]

open access: yes, 2016
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss.
Banu, Bozkurt.   +8 more
core   +2 more sources

Timolol-induced interstitial lung disease

open access: yesRespiratory Medicine Case Reports, 2015
Timolol maleate is a non-selective beta-adrenergic receptor blocking agent with demonstrated efficacy in the treatment of open-angle glaucoma. A 76 year old female who presented with productive cough, progressive dyspnea and hypoxia after starting ...
Hetain Patel   +2 more
doaj   +1 more source

Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study [PDF]

open access: yes, 2016
Purpose: The purpose of this study is to make a prospective evaluation of the effect of timolol 0.1% eye gel on short-term intraocular pressure (IOP) after an intravitreal injection (IVI) of ranibizumab. Participants and methods: One hundred and fifty
Allegrini, D.   +3 more
core   +7 more sources

Treatment patterns and outcomes in children with infantile hemangiomas: A retrospective observational analysis

open access: yesSAGE Open Medicine, 2021
Objective: This study aimed to make use of real-world medical records to explore the clinical characteristics, treatments, and outcomes of infantile hemangiomas in southeastern China. Methods: This study applied a retrospective observational method using
Yantao Cai   +6 more
doaj   +1 more source

ORAL TOPICAL TIMOLOL MALEAT OR ORAL PROPRANOLOL TREATMENT FOR INFANTILE HEMANGIOMAS: CLINICAL ANALYSIS OF 403 PATIENTS [PDF]

open access: yesSanamed, 2023
Objective: Infantile hemangiomas (IH) are the most common benign vascular tumors of infancy. Propranolol (P), a nonselective beta-blocker, has been successfully used in managing IHs.
Terzi Özlem   +9 more
doaj   +1 more source

Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily [PDF]

open access: yesActa Ophthalmologica Scandinavica, 2003
Abstract.Purpose:  To evaluate the efficacy and safety of the timolol maleate/latanoprost fixed combination (TLFC) given once each evening versus brimonidine and timolol solution given twice daily as concomitant therapy in primary open‐angle glaucoma or ocular hypertension patients.Methods:  Qualified subjects were begun on timolol alone twice daily ...
William C, Stewart   +3 more
openaire   +2 more sources

Changes in visual function after intraocular pressure reduction using antiglaucoma medications [PDF]

open access: yes, 2009
Purpose To evaluate the change in visual function after starting glaucoma treatment and correlate this to a decrease in intraocular pressure (IOP) in primary open-angle glaucoma patients.Methods A prospective, randomized clinical trial was carried out ...
A Harris   +22 more
core   +2 more sources

Home - About - Disclaimer - Privacy